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ABSTRACT: Cellular cryopreservation is a platform technology which underpins
cell biology, biochemistry, biomaterials, diagnostics, and the cold chain for emerging
cell-based therapies. This technique relies on eﬀective methods for banking and
shipping to avoid the need for continuous cell culture. The most common method to
achieve cryopreservation is to use large volumes of organic solvent cryoprotective
agents which can promote either a vitreous (ice free) phase or dehydrate and protect
the cells. These methods are very successful but are not perfect: not all cell types can
be cryopreserved and recovered, and the cells do not always retain their phenotype
and function post-thaw. This Perspective will introduce polyampholytes as emerging
macromolecular cryoprotective agents and demonstrate they have the potential to
impact a range of ﬁelds from cell-based therapies to basic cell biology and may be
able to improve, or replace, current solvent-based cryoprotective agents.
Polyampholytes have been shown to be remarkable (mammalian cell)
cryopreservation enhancers, but their mechanism of action is unclear, which may include membrane protection, solvent
replacement, or a yet unknown protective mechanism, but it seems the modulation of ice growth (recrystallization) may only
play a minor role in their function, unlike other macromolecular cryoprotectants. This Perspective will discuss their synthesis
and summarize the state-of-the-art, including hypotheses of how they function, to introduce this exciting area of
biomacromolecular science.
■ INTRODUCTION
For the cryopreservation of mammalian cells, the standard
protocol is freezing in a solution containing 5−10 wt % of the
cryoprotective agent (CPA) dimethyl sulfoxide (DMSO),
which was introduced in 19591 and remains the gold standard.
DMSO is able to enter cells and, at least partly, reduce injury
by moderating the increase in solute concentration during
freezing.2−4 While freezing in DMSO works for most cell lines
(and indeed is a key underpinning technology), there remains
many where it is not satisfactory. For example, DMSO causes
diﬀerentiation of human leukemic cell lines,5 as well as certain
cells such as leukocytes and RAW 264.7 (murine macrophage)
cells, which are highly sensitive to DMSO, with concentrations
even below 1% signiﬁcantly aﬀecting ROS production.6 In
addition to these speciﬁc instances, there is a concern with
using DMSO for all cell lines due to its cytotoxicity at high
concentrations and/or at room temperature.7,8 Emerging cell-
based therapies such as CAR-T (chimeric antigen receptor T-
cell) are now approved for some cancers including acute
lymphoblastic leukemia. One potential side eﬀect of these
therapies is from the DMSO transfusion, which in the case of
Tisagenlecleucel is 7.5 wt %, leading to nausea/vomiting.9
Removal of DMSO prior to bone marrow transfusion
complicates the process but has been shown to reduce side
eﬀects.10 DMSO can also interfere with cellular processes such
as altering the epigenetic proﬁle and hypermethylation of
cardiac and hepatic cells,11 disrupting morphology and
reducing the viability of primary neuronal cells,12 inducing
protein aggregation,13 damaging mitochondrial integrity and
promoting apoptosis in astrocytes,14 and inducing signiﬁcant
alterations in gene expression, protein content, and function-
ality of diﬀerentiated hepatic cells.15
It is, at this point, important to point out that DMSO
cryopreservation is a highly successful technology which is
essential to modern bioscience, and our aim is not to say
otherwise. But, there exists major opportunities to improve
upon it; this could be by increased cell recovery (function and
yield) or by reducing the concentration required, while
ensuring the new additives also have minimal side eﬀects.
Alternatives such as trehalose have been widely explored, but
trehalose is non-cell-permeating and hence requires either to
be used alongside a cell-penetrating cryoprotectant (such as
DMSO)16 or loading into the cell using poration methods.17,18
Currently, cells are typically frozen as suspensions in
cryovials and stored in liquid nitrogen, but a large amount of
biomedical research is conducted on adherent cells as
monolayers. However, preserving cells as attached monolayers
“ready for assays” is challenging. Inclusion of DMSO alone
does not work well for cell monolayers,19 typically resulting in
only around 20−35% recovery.20,21 Adherent attached human
embryonic stem cells yield extremely low survival rates of <5%
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which has been shown to be due to apoptosis rather than
necrosis from freeze−thaw injury.19,20 The ability to
cryopreserve cell monolayers would facilitate drug develop-
ment by providing phenotypically identical cells for assays as
well as provide insights into the cryopreservation of more
complex biological material such as spheroids or tissues.
Compared to cryopreservation of suspended cells, protocols
for adherent cell monolayers are signiﬁcantly lacking. To date,
there have been few studies on the slow-freezing (nonvitriﬁed)
cryopreservation of monolayered cells.21−33 3-D cell cultures
such as spheroids or organoids present even more complexity,
such as the signiﬁcant impact of spheroid size on recovery
(large <40% recovery vs small <70%) along with required
equilibration times,34 and hence result in lower cell yields post-
thaw. This is clearly observed with human embryonic kidney
cells, where 3-D cryopreservation led to recovery of only
36%,30 and improved methods are obviously required.
In order to improve cryopreservation outcomes and
introduce new disruptive technology, one must ﬁrst under-
stand the mechanisms by which cryopreserved tissues are
damaged. Regardless of the format the cells are frozen in, there
Figure 1. Schematic showing conventional cryopreservation process and sites of damage. Pathways for vitriﬁcation and slow cooling processes are
indicated. Point where ice recrystallization inhibiting polymers (outside of context of this Perspective) can impact is shown, and the range of
processes where membrane damage (a possible mechanism of action of polyampholytes) is also shown.
Figure 2. Common synthetic strategies used to access polyampho-
lytes. (A) Copolymerization of methacrylic acid (MAA) and 2-
(dimethylamino)ethyl methacrylate (DMAEMA). (B) Postpolymeri-
zation modiﬁcation of poly(ε-lysine) using succinic anhydride. Figure 3. (A) Synthetic scheme for the copolymerization of maleic
anhydride with styrene to produce a perfectly alternating copolymer,
followed by ring opening of the anhydride to produce a
polyampholyte. (B) Synthetic scheme for the synthesis of a
poly(DMAEMA-MAA) ampholyte, and a schematic showing how
50:50 monomer incorporation across all chains may not be evenly
distributed within a single chain.
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are two main conventional methods for freezing: slow cooling
and vitriﬁcation (Figure 1). Vitriﬁcation uses a high
concentration of solutes and ultrarapid lowering of temper-
ature generating a glassy solid while avoiding ice nucleation.35
The high CPA concentration results in dehydration of the cells
and the potential for ice crystal growth exists upon thawing.36
Additionally, the high concentration of CPA must be quickly
removed to prevent toxicity, which can involve challenging and
complex processes. Due to the high rate of freezing and high
CPA concentration required to reach a glassy state, vitriﬁcation
is not wholly practical for everyday lab use. Slow cooling
involves freezing at a controlled rate of 1 °C·min−1 in the
presence of a CPA which promotes dehydration to avoid
intracellular ice formation.37 Cells can be stored short-term at
−80 °C or moved to liquid nitrogen for long-term storage at
−196 °C. Upon thawing, as for cells that have been vitriﬁed,
ice recrystallization can damage the cells through the growth of
ice crystals at temperatures close to the freezing point of the
cryoprotectant solution. This crystal growth can cause both
mechanical and osmotic damage to cells, and being able to
control this process by using ice recrystallization inhibitors has
been shown to result in enhanced post-thaw recovery.38 In
either process, membrane damage can occur at any point
where there is molecular movement (>−80 °C). Cellular
membranes function universally as barriers between the
environment as well as individual cellular components, play a
major role in molecule transport and bioenergetics, and are of
critical importance in cell signaling processes. The bilayer
typically exists in what is commonly termed a liquid-crystalline
phase (a balance between ﬂexibility and order) and at
Figure 4. (A) IRI (ice recrystallization inhibition) activity and viability of a carboxylated poly(ε-lysine) with varying ratios of carboxylation.60 (B)
IRI activity represented as mean largest grain size for varying ratios of anionic to cationic monomers in a vinyl-based polymer.80
Table 1. Summary of IRI Activity and Cell Recovery Using a Panel of Polyampholytes and Polyzwitterions61
aStructure of the polyampholyte tested. bPost-thaw viability of L929 cells cryopreserved using 100 mg·mL−1 polyampholyte, and cooling to −80 °C
without controling the cooling rate. cIRI activity given as MLGS (mean largest grain size) and compared to a phosphate-buﬀered saline control.
Polymers were tested at 100 mg·mL−1.
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suﬃciently low temperatures the regions of the bilayer enter
what is termed a gel phase, however, due to the heterogeneity
of the bilayer, liquid- and gel-phase regions may coexist in the
membrane throughout the cooling process, which results in
phase separation.39 Phase separated membranes have been
shown to have an increased permeability at the interface of the
two regions40 and upon reheating, phase separated membranes
can form nonbilayer lipid structures, due to lipid aggregation,39
which results in membrane integrity damage.41 There are
clearly many opportunities to tackle these challenges using
both organic and macromolecular chemistry.
In contrast to traditional cryopreservation strategies, Nature
has evolved a remarkable series of ice binding (also known as
antifreeze) proteins and biomacromolecules, enabling extrem-
ophiles to survive at subzero temperatures. Antifreeze proteins
from polar ﬁsh are the most studied class, and provide a
noncolligative freezing point depression of their internal ﬂuids,
preventing damage caused by freezing.42−44 Cryoprotectant
macromolecules have also been found in insects and plants
(including proteins45,46 and polysaccharides47). In particular
their ice recrystallization inhibition (IRI) activity has generated
interest, due to the detrimental role of ice recrystallization in
cell cryopreservation. A challenge in their application, however,
is that their eﬃcient ice binding causes dynamic ice shaping of
the crystals, leading to spicular (needle like) growth which can
pierce cells and disrupt cell membranes, limiting their
eﬀectiveness.48 There has therefore been signiﬁcant interest
in macromolecular cryoprotectants (see reviews49−51) which
show IRI activity and have shown some beneﬁt in the
cryopreservation of cells.52−55 Similarly small molecule IRI’s
from Ben and co-workers have shown potential to modulate
this mode of damage.56−59 However, it is clear that IRI alone
does not modulate all damage to cells, and that other
mechanism of cell death, and hence other materials, are
required to transform the biologic and biotechnological cold
chain for cells.
In 2009, Matsumura and Hyun reported the remarkable
cryopreservative activity of carboxylated poly(ε-lysine)a
polyampholyte.60 Addition of 10 wt % of this polymer enabled
the recovery of viable cells, but its protective eﬀect does not
seem to be down to the ice recrystallization inhibition alone.
Its core structure (balance of cationic/anionic groups) also
does not seem to link to known biological macromolecular
cryoprotectants, but the need for a polymeric backbone is
clear. It is now emerging that many polymers based on the
ampholyte structure show cryoprotective beneﬁts without any
signiﬁcant impact on ice recrystallization,61−65 but the
mechanism of action, core structural motifs and translational
potential is still to be explored.
In this Perspective, we will discuss the new but rapidly
evolving ﬁeld of polyampholytes for cryopreservation. This will
include a short commentary on their synthesis and properties
followed by a critical evaluation of their application and
potency in cell cryopreservation and thoughts on how the ﬁeld
will develop.
Synthesis of Polyampholytes. Polyampholytes, or mixed
charge polymers, were ﬁrst synthesized by Alfrey in 1950, as a
“synthetic alternative to proteins using copolymers of 2-
vinylpyridine and methacrylic acid which demonstrated similar
solubility and electrophoretic mobility to proteins.66 The
deﬁnition of a polyampholyte can overlap with that of
polyzwitterions and polybetaines depending on the nature of
the functional group.67 In the context of this article,
polyampholytes will be deﬁned as polymers which contain
mixed cationic/anionic groups but not those where the charge
is on the same repeat unit, where we will refer to it as
polybetaines. This Perspective will only consider polyampho-
lytes in the context of cryopreservation, but it is important to
highlight the many other application areas of polyzwitterions in
general, such as in drag reducers or anti-fouling coatings.68−70
There are a variety of synthetic strategies which can be used
to access polyampholytes, either by the direct copolymeriza-
tion of the appropriate monomers (Figure 2A)71,72 (with or
without protecting groups) or by postpolymerization mod-
iﬁcation (Figure 2B).60 A number of polyampholytes with
more complex architectures have been synthesized by
Figure 5. (A) Synthesis and application of a polyampholyte derived
from the commodity polymer poly(methyl vinyl ether-alt-maleic
anhydride). (B) Suspension cryopreservation of A549 cells using the
polyampholyte showing total cells recovered. (C) Monolayer
cryopreservation of A549 cells using the polyampholyte showing
total cells recovered. Results show total cell recovery as a function of
both polyampholyte and DMSO concentration. Reproduced with
permission from Bailey et al.24 Copyright 2019 American Chemical
Society.
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exploiting controlled radical polymerization methods, for
example triblock copolymers of methacrylic acid (MAA) and
2-(dimethylamino)ethyl methacrylate (DMAEMA) and either
methyl methacrylate or 2-phenylethyl methacrylate using
group transfer polymerization,73 or polyampholytes based on
substituted styrenes using nitroxide mediated polymerization.74
More recently, the ring-opening polymerization of an N-
maleamic acid functionalized homocysteine thiolactone mono-
mer has been exploited by Du Prez and co-workers to
synthesize purely alternating polyampholytes with no composi-
tional drift.75 Polyampholytes made by most copolymerization
methods are limited by their inherent compositional variability,
with few individual chains having monomer compositions
matching the feed ratio. A powerful strategy to overcome this
is to use the unique reactivity of maleic anhydride (MAH).
Maleic anhydride cannot homopolymerize as the reaction
between the growing MAH polymer radical and the monomer
unit is strongly disfavored when compared to cross
propagation. Therefore, with appropriate choice of como-
nomer, perfectly alternating materials can be obtained (Figure
3A). The anhydride ring in the polymer backbone can be ring
opened using appropriate nucleophiles to introduce the
cationic functionality (e.g., a tertiary amine) and simulta-
neously a carboxylic acid. This method is particularly useful as
it ensures a 1:1 ratio of the charged groups, whereas other
copolymerization strategies lead to some compositional
variation (Figure 3B). Advances in sequence controlled
polymers will no doubt oﬀer opportunities in the future to
access precision polyampholytes.76
Polyampholytes as Macromolecular Cryoprotectants.
In the context of macromolecular cryopreservation, there have
been several reports on using polymers which have IRI activity
to enhance post-thaw cell recovery, which is outside the
context of this Perspective.49,50,58,77−79 However, evidence is
emerging that IRI activity alone often only gives incremental
beneﬁts, and has so far not enabled to dramatically remove
organic solvents from mammalian cell cryopreservation. In
short, ice recrystallization is part of the cryopreservation
problem but not the only one, with issues such as membrane
damage and apoptosis not addressed. In contrast polyampho-
lytes, which have only modest/weak IRI and seem to function
by an alternative mechanism, are attracting attention.
Carboxylated poly(ε-lysine) was the ﬁrst polyampholyte
cryoprotectant, and was observed to enhance the viability of
cryopreserved L929 cells to as high as 95% [note, viability is
not the same as total cell recovery] using a slow freezing (1 °C·
min−1) process (Figure 4). The ratio of anionic and cationic
groups was found to be crucial, with a ratio close to 1:1
essential for the best cryopreservation results, demonstrating
the ampholyte structure is essential (Figure 4A).60
To investigate if polyampholytes have IRI activity (as a
potential mechanism of action for cryopreservation), Mitchell
et al. used reversible addition−fragmentation chain transfer
(RAFT) polymerization to produce poly(aminoethyl meth-
acrylate) (PAEMA), followed by reaction with succinic
anhydride to give a polyampholyte. The ratio of positive to
negative charges was systematically varied, and the IRI activity
evaluated. It was observed that IRI activity was highest when a
1:1 ratio of charges were used, with activity being lost as one
Table 2. Cryoprotective Outcomes Using Polyampholytes
Structurea
[Polymer]
(wt %) Cell type Cell viabilityb Freezing ratec Other CPAsd Ref
2 7 L929 ∼95% Slow freezing
1 °C·min−1
None 60
3 15 L929 ∼90% Slow freezing NCe None 62
4 10 L929 ∼95% Slow freezing NCe None 63
5 15 <10%
6 15 ∼70%
7 2 RBC ∼65% Vitriﬁcation direct
into LN2
350 mg·mL−1 HES, 30 mg·mL−1 mannitol and 6.5
mg·mL−1 NaCl
65
8 12 L929 ∼90% Slow freezing NCe None 87
2 10 MSC Monolayer ∼80% Slow freezing
4.9 °C·min−1
6.5 M EGf, 0.5 M sucrose 25
3 10 L929 ∼60% Slow freezing NCe None 61
9 10 ∼70%
4 10 96%
10 10 3T3 70% Slow freezing
1 °C·min−1
2% DMSO 83
11 10 90%
2 20 PN Pig embryo Higher development
rate
Vitriﬁcation direct
into LN2
30% EGf, 0.5 M sucrose 91
2 10 Chondrocyte sheet All sheets recovered Vitriﬁcation direct
into LN2
20% DMSO, 20% EGf, 0.5 M sucrose 89
2 10 Mouse oocyte 95% Survival after
fertilization
Vitriﬁcation direct
into LN2
20% EGf, 0.5 M sucrose 90
2 7.5 Human mesenchymal
stem cells
90% Viability after 24
months
Slow freezing NCe None 93
1 2 A549 Suspension 50% Slow freezing
1 °C·min−1
5% DMSO 24
1 4 A549 Monolayer 90% Slow freezing
1 °C·min−1
5% DMSO
aRepresentative structure reproduced from reference. bViability of the cells as reported. cIf included in original ref. dAny other materials added to
the cryopreservation solution. eNot controlled, ﬁnal storage temperature −80 °C. fEG is ethylene glycol.
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group starts to dominate (Figure 4B).80 It must be noted,
however, that the overall activity was rather low compared to
other IRI active materials.81 Interestingly, zwitterionic
polymers (where both charges are on each repeat unit) were
found to have no activity, indicating the correct location,
chemical nature and distribution of the charges is a key
structural requirement.80
In order to investigate the importance of regioregularity on
the IRI activity of polyampholytes, Stubbs et al. synthesized a
selection of alternating copolymers using RAFT/MADIX
polymerization of maleic anhydride to generate polymer
materials using comonomers of varying hydrophobicity,
followed by the subsequent ring-opening of the anhydride to
install the charged groups. It was shown that the appropriate
balance of hydrophobicity in both the comonomer and
pendant amine are required in order to maximize IRI activity.
Polymers functionalized with dimethylaminoethanol displayed
more IRI activity than those functionalized with either NH2 or
NiPr2 groups, suggesting a balance of hydrophobicity/philicity
is required. These copolymers were then also compared to
structurally similar materials synthesized through random
copolymerization of acrylic acid (AA) and dimethylaminoethyl
acrylate (DMEA) demonstrating the importance of this
regioregular distribution of charges.82
Copolymers obtained from 2-(dimethylamino)ethyl meth-
acrylate and methacrylic acid (at 1:1 ratio) showed some
increase in cryoprotective and IRI activity when hydro-
phobicity was increased (noting that the concentrations used
for IRI testing were very high and hence activity in these cases
was very weak).62 The eﬀect of this hydrophobicity increase to
cryoprotectant activity was then investigated further, with
hydrophobically modiﬁed p(DMAEMA-MAA) compared to
poly carboxymethyl betaine (poly(CMB)) and poly sulfobe-
taine (poly(SPB)), and their hydrophobically modiﬁed
counterparts. Hydrophobic modiﬁcation of p(DMAEMA-
MAA) enhanced activity from ∼60% to 90% recovery.
Interestingly, poly(CMB), which has a remarkably similar
structure to poly(DMAEMA-MAA), was shown to demon-
strate no cryoprotective properties, and that hydrophobic
modiﬁcation had no eﬀect on its activity. Poly(SPB), however,
showed no change in activity after hydrophobic modiﬁcation,
suggesting that this is not a guaranteed method by which to
enhance cryoprotectant activity.63 Table 1 summarizes some
polyampholytes, their IRI activity, and post-thaw cell viability,
highlighting the lack of trend between the two. [Note; IRI
activity is deﬁned by the mean largest grain size here−the
values can be between 0 and 100%, with 100% representing no
activity (the same as a negative control).]
It is crucial to highlight here that all the reported
polyampholytes only have very weak IRI (or other properties
associated with ice growth modulation), requiring concen-
trations 10−50-fold higher than PVA, and 100s of times higher
than antifreeze proteins. It is therefore important to highlight
that it is not clear if IRI or another entirely separate
Figure 6. Chemical structures of polyampholytes referred to in Table 2.
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mechanism is responsible for their observed cryoprotective
properties and it may be possible that the weak IRI is
coincidental and not crucial. See previous reviews for details of
IRI and macromolecules.49,50,81
Other investigations into fully synthetic ampholytes have
demonstrated that a copolymer of dimethylaminopropyl
methacrylamide and acrylic acid are eﬃcient cryoprotectants
for the DMSO-free cryopreservation of 3T3 cells. It was
observed that with the inclusion of 9% hydrophobic N-tbutyl
acrylamide, 90% recovery (relative to 10% DMSO) was
observed immediately post-thaw; however, long-term (up to
72 h) viability was poorer. This highlights a key issue in that
many additives can enable cell recovery, but retaining viable
cells after >24 h of culture is challenging, but also essential for
all downstream applications. The addition of 2% DMSO
helped to reduce this loss, with results comparable to 10%
DMSO alone.83 This highlights a crucial point for assessing
cryopreservation success, since the process of freezing and
thawing cells has been shown to induce stress and the
upregulation of apoptosis proteins in many cell types,19,20,84
leading to subsequent cell death occurring up to 24 h post-
thaw.85 Analyzing cell recovery immediately post-thaw often
overlooks this process and can lead to false-positives of
cryopreservation success.86 Therefore, it is crucial in this ﬁeld
to enable suﬃcient time (normally at least 24 h) post-thaw to
be conﬁdent of a cryopreservation result.
Matsumura has also developed dextran-based polyampholyte
cryoprotectants, which form in situ hydrogels via a biocompat-
ible copper-free click reaction. These hydrogels were then used
for the DMSO-free cryopreservation of mammalian cells.87
Given the successes observed using polyampholytes to aid in
suspension freezing, Matsumura also investigated the applic-
ability of these materials for the cryopreservation of cellular
monolayers.25 Monolayers are signiﬁcantly more diﬃcult to
freeze88 while also acting as a more realistic substitute for
organs and tissues.23 It was observed that DMSO can be
omitted during slow vitriﬁcation by using an alternative
cryoprotectant solution of 6.5 M ethylene glycol, 10 wt %
COOH-εPLL and 0.5 M sucrose. Freezing rates as low as 4.9
°C·min−1 were used, with good recovery of the cells
immediately after thawing and after 1 day of cell culture.
COOH-εPLL has since been shown to be eﬀective for the
cryopreservation of a wide variety of other cell types, for
example chondrocyte cell sheets,89 mouse oocytes,90 pig91 and
mouse92 embryos and long-term studies on human mesen-
chymal stem cells.93
However, these polymers are based on relatively expensive
precursors (such as poly(ε-lysine)); for larger scale cryopre-
servation, grams to kilograms are required. To address this
issue, Mitchell et al. reported using the commercially available
ampholyte precursor poly(methyl vinyl ether-alt-maleic anhy-
dride), (poly(MVE-alt-MA)). This material was functionalized
with a Boc protected aminoethanol, followed by deprotection
to generate a polyampholyte with exact 1:1 charge ratios, and
then applied to the cryopreservation of blood cells via a slow
thawing mechanism that gave excellent recovery when paired
with hydroxyethyl starch as a cocryoprotectant.65 Given the
activity of these materials, the potential of maleic anhydride
copolymers as ampholyte precursors was determined to be of
interest. Poly(MVE-alt-MA) is produced using a standard free
radical polymerization, which while eﬃcient and low cost, leads
to little control over the molecular weight, dispersity, and
monomer incorporation of the polymer. Following on from
this, Gibson and co-workers have developed a polymer based
on poly(MVE-alt-MA) which is available commercially on a
multikilogram basis, is used as a bioadhesive and available to
good manufacturing practice (GMP) quality, which is
important for biomedical applications.94 The poly(MVE-alt-
MA) copolymer is easily ring opened with dimethylaminoe-
thanol to give an ampholytic structure (Figure 5A). The choice
of dimethylamine (rather than, e.g., primary amine) as the
positive charge was essential to maximize performance versus
solubility, as found using previous polyampholytes.82 This
polymer was shown to enable suspension cryopreservation of
A549 cells using just 2.5 wt % DMSO (in place of the normal
10 wt %) (Figure 5). Additionally, it was found to improve the
cryopreservation of A549 monolayers from around 20 to
almost 90%, with a similar fold increase seen with other cell
lines. This showed that polyampholytes may be translatable
from the laboratory to a real-world scenario by using a
commercially valid scaﬀold.
Table 2/Figure 6 collates the currently (to the best of our
knowledge) reported cells and cryopreservation conditions
where polyampholytes have been used. It is crucial to note
there is no standardized test for cryopreservation, so many
features such as cell density, freezing/thawing rates and the
addition or absence of serum can all aﬀect the outcomes. Also,
each cell type has a diﬀerent growth rate and diﬀerent media
requirements (which may also aﬀect cryopreservation out-
comes), so it is not possible to compare between them. What is
crucial is to note, in Table 2, which cases are vitriﬁcation (ice
free, using larger volumes of solvents) and which are slow
freezing (ice is allowed to form), as these are technically
diﬀerent processes and the polyampholytes appear to give
beneﬁts in both cases. Furthermore, only cell viability is
reported, not cell recovery, as this is the most commonly used
output, enabling comparison. We would highlight, however,
that obtaining viable cells is important, but so is the total cell
yield; for example, obtaining cells with viability >90%, but only
recovering 1% of what went in the vial is clinically and
biochemically not a useful process, but this number is less
commonly reported.
Mechanism of Cryoprotection. In an attempt to
understand the mechanism by which polyampholytes provide
eﬃcient protection, Matsumura investigated the eﬀect of three
diﬀerent cryoprotective polymers on the integrity of the cell
membrane. Samples which gave greater cellular recovery post-
thaw were shown to cause a greater depression in the gel−
liquid phase-transition temperature of model phospholipid
membranes. Leakage experiments also suggested that the
polymers were interacting with the membranes, with improved
cryoprotective activity corresponding to less post-thaw leakage
from a cryopreserved liposome.61 This membrane interaction
has also been exploited by Matsumura for the introduction of
lysozyme proteins into cells through a freeze−thaw mecha-
nism, which enables a 4-fold increase in uptake when
compared to nonfrozen cells.95 It was then demonstrated
that these ampholyte-based nanocarrier complexes allowed
more protein internalization when compared to 10% DMSO,
which is known to enhance membrane permeability.96 Taken
together, these results suggest that while also providing
superior cell viability post-thaw, polyampholytes interact with
the cell membrane during the freezing process to allow greater
payload uptake when incorporated into a protein−nanocarrier
complex.
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Poly(zwitterions) have been investigated for gene and drug
delivery, to mitigate the toxicity of fully cationic polymers.
While beyond the scope of this Perspective, it appears these
delivery mechanisms are also reliant on the ability of
polyampholytes to engage with cell membranes. Interestingly,
bacteria cell membranes have a higher density of anionic lipids
compared to mammalian cell membranes. A study by Hasan et
al. has shown that polyampholytes fail to oﬀer any
cryoprotective eﬀect to a range of bacteria, despite their
near-universal role in enhancing mammalian cryopreservation,
providing further evidence for the role of membrane
interactions (while remembering there are other signiﬁcant
diﬀerences between prokaryotes and eukaryotic cells).97
Future Perspective. This Perspective has gathered
compelling examples that polyampholytes are potent macro-
molecular cryopreservatives which enhance the cryopreserva-
tion of a vast range of cell types. The cryoprotective capability
of these appears to be remarkably tolerant of the actual
structure of the polyampholytes, based on available evidence,
with a range of backbones and functionalities possible.
However, this diversity of structures does mean there are
major knowledge gaps in exactly how these polymers function,
and to what extent than can be employed within both basic
biomedical research and also clinical applications, where
formulations using DMSO as the major cryoprotective agent
are successfully used and integrated into supply chains. There
is also the issue of cost, compared to DMSO alone, and the
role of other cryoprotectants such as trehalose to look for
synergistic beneﬁts. Furthermore, there is the question of
whether routine addition of these polymers can improve
workﬂows or enable the cryopreservation of emerging, more
challenging, cell systems particularly in 2 and 3 dimensions,
where current methods are not suitable. In order to advance
this ﬁeld, a detailed molecular level understanding of their
function is essential as well as consideration of how they can be
incorporated into both routine (e.g., lab based) and
therapeutic cryopreservation protocols. This will include issues
such as ensuring shelf stability, solubility (due to the high
concentrations required) as well as biocompatibility. We also
postulate it is key to highlight that a polymer which controls
ice growth may give a beneﬁt to cryopreservation; however, a
material which beneﬁts cryopreservation may not necessarily
impact ice growth. We therefore anticipate signiﬁcant interest
in these materials in the coming years, especially to obtain
quantitative structure−activity relationships to help guide them
to real-world applications.
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D. H. Synthetic Polyampholytes as Macromolecular Cryoprotective
Agents. Langmuir 2019, 35 (5), 1807−1817.
(84) Baust, J. M.; Buskirk, R. V. A. N.; Baust, J. G. Cell Viability
Improves Following Inhibition of Cryopreservation-Induced Apopto-
sis. Vitr. Cell. Dev. Biol. - Anim. 2000, 36 (April), 262−270.
(85) Suzuki, K.; Kostin, S.; Person, V.; Elsas̈ser, A.; Schaper, J. Time
Course of the Apoptotic Cascade and Effects of Caspase Inhibitors in
Adult Rat Ventricular Cardiomyocytes. J. Mol. Cell. Cardiol. 2001, 33
(5), 983−994.
(86) Baust, J. M.; Vogel, M. J.; Van Buskirk, R.; Baust, J. G. A
Molecular Basis of Cryopreservation Failure and Its Modulation to
Improve Cell Survival. Cell Transplant 2001, 10 (7), 561−571.
(87) Jain, M.; Rajan, R.; Hyon, S.-H.; Matsumura, K. Hydrogelation
of Dextran-Based Polyampholytes with Cryoprotective Properties via
Click Chemistry. Biomater. Sci. 2014, 2 (3), 308−317.
(88) Armitage, W. J.; Juss, B. K. The Influence of Cooling Rate on
Survival of Frozen Cells Differs in Monolayers and in Suspensions.
Cryo-Letters 1996, 17, 213−218.
(89) Maehara, M.; Sato, M.; Watanabe, M.; Matsunari, H.; Kokubo,
M.; Kanai, T.; Sato, M.; Matsumura, K.; Hyon, S. H.; Yokoyama, M.;
Mochida, J.; Nagashima, H. Development of a Novel Vitrification
Method for Chondrocyte Sheets. BMC Biotechnol. 2013, 13 (1), 58.
(90) Watanabe, H.; Kohaya, N.; Kamoshita, M.; Fujiwara, K.;
Matsumura, K.; Hyon, S. H.; Ito, J.; Kashiwazaki, N. Efficient
Production of Live Offspring from Mouse Oocytes Vitrified with a
Novel Cryoprotective Agent, Carboxylated ε-Poly-L-Lysine. PLoS One
2013, 8 (12), e83613.
(91) Kamoshita, M.; Kato, T.; Fujiwara, K.; Namiki, T.; Matsumura,
K.; Hyon, S. H.; Ito, J.; Kashiwazaki, N. Successful Vitrification of
Pronuclear-Stage Pig Embryos with a Novel Cryoprotective Agent,
Carboxylated ϵ-Poly-L-Lysine. PLoS One 2017, 12 (4), e0176711.
(92) Shibao, Y.; Fujiwara, K.; Kawasaki, Y.; Matsumura, K.; Hyon,
S.-H.; Ito, J.; Kashiwazaki, N. The Effect of a Novel Cryoprotective
Agent, Carboxylated ε-Poly-l-Lysine, on the Developmental Ability of
Re-Vitrified Mouse Embryos at the Pronuclear Stage. Cryobiology
2014, 68 (2), 200−204.
(93) Matsumura, K.; Hayashi, F.; Nagashima, T.; Hyon, S. H. Long-
Term Cryopreservation of Human Mesenchymal Stem Cells Using
Carboxylated Poly-l-Lysine without the Addition of Proteins or
Dimethyl Sulfoxide. J. Biomater. Sci., Polym. Ed. 2013, 24 (12), 1484−
1497.
Biomacromolecules Perspective
DOI: 10.1021/acs.biomac.9b01053
Biomacromolecules XXXX, XXX, XXX−XXX
J
(94) Iglesias, T.; Dusinska, M.; El Yamani, N.; Irache, J. M.; Azqueta,
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